Real time monitoring and prediction of time to endpoint maturation in clinical trials
In clinical trials, almost all key milestone dates can be defined in terms of time to endpoint maturation (TTEM). The real time monitoring and accurate prediction of TTEM have a significant impact on clinical trial planning and execution and can bring significant value to clinical trial practitioner...
Saved in:
Published in | Statistics in medicine Vol. 41; no. 18; pp. 3596 - 3611 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
15.08.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 0277-6715 1097-0258 1097-0258 |
DOI | 10.1002/sim.9436 |
Cover
Abstract | In clinical trials, almost all key milestone dates can be defined in terms of time to endpoint maturation (TTEM). The real time monitoring and accurate prediction of TTEM have a significant impact on clinical trial planning and execution and can bring significant value to clinical trial practitioners. TTEM is defined as the time to achieve or observe a certain number or percentage of some endpoint of interest. It is a combination of time to site initiation, time to subject enrollment after site initiation and time to event of interest after subject enrollment. To better predict TTEM during the trial, the future site initiation and subject enrollment have to be taken into account while predicting the number of events. In this article, we propose a novel simulation‐based framework combining time to site initiation, time to subject enrollment and time to event in order to predict TTEM. A nonhomogeneous Poisson process with a quadratic time‐varying rate function is used to model site initiation and subject enrollment and more advanced time to event models had been explored and integrated on top of them, such as Weibull, piecewise exponential, and model averaging which is equivalent to a Bayesian model selection strategy. To evaluate the predictive performance of the proposed methodology, we conducted extensive simulations and applied the methodology to 14 randomly selected real oncology phase 2 and phase 3 studies in both solid tumor and hematology with a total 31 study‐endpoint combinations. The predictive performance of the proposed methodology was then compared with popular and commonly available commercial software, for example, East (Cytel, Cambridge, MA, USA). From both simulation and real data, the proposed methodology can significantly improve the prediction accuracy by up to 54% compared to the commonly available method. |
---|---|
AbstractList | In clinical trials, almost all key milestone dates can be defined in terms of time to endpoint maturation (TTEM). The real time monitoring and accurate prediction of TTEM have a significant impact on clinical trial planning and execution and can bring significant value to clinical trial practitioners. TTEM is defined as the time to achieve or observe a certain number or percentage of some endpoint of interest. It is a combination of time to site initiation, time to subject enrollment after site initiation and time to event of interest after subject enrollment. To better predict TTEM during the trial, the future site initiation and subject enrollment have to be taken into account while predicting the number of events. In this article, we propose a novel simulation‐based framework combining time to site initiation, time to subject enrollment and time to event in order to predict TTEM. A nonhomogeneous Poisson process with a quadratic time‐varying rate function is used to model site initiation and subject enrollment and more advanced time to event models had been explored and integrated on top of them, such as Weibull, piecewise exponential, and model averaging which is equivalent to a Bayesian model selection strategy. To evaluate the predictive performance of the proposed methodology, we conducted extensive simulations and applied the methodology to 14 randomly selected real oncology phase 2 and phase 3 studies in both solid tumor and hematology with a total 31 study‐endpoint combinations. The predictive performance of the proposed methodology was then compared with popular and commonly available commercial software, for example, East (Cytel, Cambridge, MA, USA). From both simulation and real data, the proposed methodology can significantly improve the prediction accuracy by up to 54% compared to the commonly available method. In clinical trials, almost all key milestone dates can be defined in terms of time to endpoint maturation (TTEM). The real time monitoring and accurate prediction of TTEM have a significant impact on clinical trial planning and execution and can bring significant value to clinical trial practitioners. TTEM is defined as the time to achieve or observe a certain number or percentage of some endpoint of interest. It is a combination of time to site initiation, time to subject enrollment after site initiation and time to event of interest after subject enrollment. To better predict TTEM during the trial, the future site initiation and subject enrollment have to be taken into account while predicting the number of events. In this article, we propose a novel simulation-based framework combining time to site initiation, time to subject enrollment and time to event in order to predict TTEM. A nonhomogeneous Poisson process with a quadratic time-varying rate function is used to model site initiation and subject enrollment and more advanced time to event models had been explored and integrated on top of them, such as Weibull, piecewise exponential, and model averaging which is equivalent to a Bayesian model selection strategy. To evaluate the predictive performance of the proposed methodology, we conducted extensive simulations and applied the methodology to 14 randomly selected real oncology phase 2 and phase 3 studies in both solid tumor and hematology with a total 31 study-endpoint combinations. The predictive performance of the proposed methodology was then compared with popular and commonly available commercial software, for example, East (Cytel, Cambridge, MA, USA). From both simulation and real data, the proposed methodology can significantly improve the prediction accuracy by up to 54% compared to the commonly available method.In clinical trials, almost all key milestone dates can be defined in terms of time to endpoint maturation (TTEM). The real time monitoring and accurate prediction of TTEM have a significant impact on clinical trial planning and execution and can bring significant value to clinical trial practitioners. TTEM is defined as the time to achieve or observe a certain number or percentage of some endpoint of interest. It is a combination of time to site initiation, time to subject enrollment after site initiation and time to event of interest after subject enrollment. To better predict TTEM during the trial, the future site initiation and subject enrollment have to be taken into account while predicting the number of events. In this article, we propose a novel simulation-based framework combining time to site initiation, time to subject enrollment and time to event in order to predict TTEM. A nonhomogeneous Poisson process with a quadratic time-varying rate function is used to model site initiation and subject enrollment and more advanced time to event models had been explored and integrated on top of them, such as Weibull, piecewise exponential, and model averaging which is equivalent to a Bayesian model selection strategy. To evaluate the predictive performance of the proposed methodology, we conducted extensive simulations and applied the methodology to 14 randomly selected real oncology phase 2 and phase 3 studies in both solid tumor and hematology with a total 31 study-endpoint combinations. The predictive performance of the proposed methodology was then compared with popular and commonly available commercial software, for example, East (Cytel, Cambridge, MA, USA). From both simulation and real data, the proposed methodology can significantly improve the prediction accuracy by up to 54% compared to the commonly available method. |
Author | Pulkstenis, Erik Liu, Yang Wang, Li Chen, Xiaotian |
Author_xml | – sequence: 1 givenname: Li surname: Wang fullname: Wang, Li organization: AbbVie Inc – sequence: 2 givenname: Yang surname: Liu fullname: Liu, Yang organization: AbbVie Inc – sequence: 3 givenname: Xiaotian orcidid: 0000-0002-3094-8922 surname: Chen fullname: Chen, Xiaotian email: justinchen87@gmail.com organization: AbbVie Inc – sequence: 4 givenname: Erik surname: Pulkstenis fullname: Pulkstenis, Erik organization: AbbVie Inc |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35587584$$D View this record in MEDLINE/PubMed |
BookMark | eNp10U1LxDAQBuAgiq6r4C-QghcvXZOmaZqjiF-gCH6cQ9pMJdIma5Ii--_N7roKoqcJ5JlhmHcfbVtnAaEjgmcE4-IsmGEmSlptoQnBgue4YPU2muCC87zihO2h_RDeMCaEFXwX7VHGas7qcoJeHkH1WTQDZIOzJjpv7GumrM7mHrRpo3E2c91aRJeB1XNnbMwGFUevVt_GZm1vrGmXk7xRfThAO10qcPhVp-jl6vL54ia_e7i-vTi_y1taiiovtWaqqTgWrCJlJxQHSusOVHoXVEAJpGpU0xCmVa1r2ibLMWs6DmWthaZTdLqeO_fufYQQ5WBCC32vLLgxyKJKDTWjpEj05Bd9c6O3abukBCYU80okdfylxmYALefeDMov5OZgCczWoPUuBA-dbE1cnSF6ZXpJsFwmIlMicpnIz4rfDZuZf9B8TT9MD4t_nXy6vV_5TyYQmZ4 |
CitedBy_id | crossref_primary_10_1002_pst_2343 crossref_primary_10_1088_1361_6560_acfa5e crossref_primary_10_1007_s43441_023_00564_8 |
Cites_doi | 10.1002/sim.2956 10.1002/sim.1576 10.1002/sim.8036 10.1016/j.cct.2015.07.010 10.1177/1740774517750633 10.1002/pst.525 10.1080/10543400600609445 10.1016/j.cct.2015.11.008 10.1191/1740774504cn030oa 10.1002/sim.843 10.1080/03610926.2011.581189 10.1002/pst.271 10.1016/j.cct.2011.05.013 10.1002/bimj.201100180 10.1007/978-3-7908-1952-6_1 10.2307/2533197 10.1007/978-0-387-84858-7 |
ContentType | Journal Article |
Copyright | 2022 John Wiley & Sons Ltd. 2022 John Wiley & Sons, Ltd. |
Copyright_xml | – notice: 2022 John Wiley & Sons Ltd. – notice: 2022 John Wiley & Sons, Ltd. |
DBID | AAYXX CITATION NPM K9. 7X8 |
DOI | 10.1002/sim.9436 |
DatabaseName | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Statistics Public Health |
EISSN | 1097-0258 |
EndPage | 3611 |
ExternalDocumentID | 35587584 10_1002_sim_9436 SIM9436 |
Genre | article Journal Article |
GroupedDBID | --- .3N .GA 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANLZ AAONW AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABIJN ABJNI ABOCM ABPVW ACAHQ ACCFJ ACCZN ACGFS ACPOU ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHMBA AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AUFTA AZBYB AZVAB BAFTC BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EBS EMOBN F00 F01 F04 F5P G-S G.N GNP GODZA H.T H.X HBH HGLYW HHY HHZ HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K ROL RWI RX1 RYL SUPJJ SV3 TN5 UB1 V2E W8V W99 WBKPD WH7 WIB WIH WIK WJL WOHZO WQJ WRC WUP WWH WXSBR WYISQ XBAML XG1 XV2 ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGXDD AGYGG AIDQK AIDYY AMVHM CITATION NPM K9. 7X8 |
ID | FETCH-LOGICAL-c3496-4dd5ab67095614f9a7e338fea4f9239e4e16babb15da8d83cb67705bf7e48d9d3 |
IEDL.DBID | DR2 |
ISSN | 0277-6715 1097-0258 |
IngestDate | Thu Jul 10 17:50:09 EDT 2025 Sat Sep 06 17:43:13 EDT 2025 Mon Jul 21 06:00:24 EDT 2025 Thu Apr 24 22:53:13 EDT 2025 Wed Oct 01 04:09:09 EDT 2025 Wed Jan 22 16:23:29 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 18 |
Keywords | time to event Poisson process Bayesian enrollment |
Language | English |
License | 2022 John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3496-4dd5ab67095614f9a7e338fea4f9239e4e16babb15da8d83cb67705bf7e48d9d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-3094-8922 |
PMID | 35587584 |
PQID | 2690130769 |
PQPubID | 48361 |
PageCount | 16 |
ParticipantIDs | proquest_miscellaneous_2667785312 proquest_journals_2690130769 pubmed_primary_35587584 crossref_citationtrail_10_1002_sim_9436 crossref_primary_10_1002_sim_9436 wiley_primary_10_1002_sim_9436_SIM9436 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 15 August 2022 |
PublicationDateYYYYMMDD | 2022-08-15 |
PublicationDate_xml | – month: 08 year: 2022 text: 15 August 2022 day: 15 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: New York |
PublicationTitle | Statistics in medicine |
PublicationTitleAlternate | Stat Med |
PublicationYear | 2022 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2015; 45 2020 2006; 16 2011; 40 2009 2019; 38 2007 2008; 7 2011; 10 2011; 32 2004; 1 1994; 50 2012; 54 2018; 15 2016; 46 2001; 20 2007; 26 2003; 22 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 Anisimov VV (e_1_2_8_7_1) 2020 e_1_2_8_10_1 e_1_2_8_11_1 e_1_2_8_12_1 |
References_xml | – volume: 38 start-page: 945 issue: 6 year: 2019 end-page: 955 article-title: Statistical modeling and prediction of clinical trial recruitment publication-title: Stat Med – year: 2009 – volume: 22 start-page: 3431 issue: 22 year: 2003 end-page: 3447 article-title: Methods for mid‐course corrections in clinical trials with survival outcomes publication-title: Stat Med – start-page: 1 year: 2007 end-page: 8 – volume: 10 start-page: 517 issue: 6 year: 2011 end-page: 522 article-title: Predictive event modelling in multicenter clinical trials with waiting time to response publication-title: Pharm Stat – volume: 7 start-page: 107 issue: 2 year: 2008 end-page: 120 article-title: Weibull prediction of event times in clinical trials publication-title: Pharm Stat – volume: 15 start-page: 159 issue: 2 year: 2018 end-page: 168 article-title: Adaptive parametric prediction of event times in clinical trials publication-title: Clin Trials – volume: 1 start-page: 352 issue: 4 year: 2004 end-page: 361 article-title: Nonparametric prediction of event times in randomized clinical trials publication-title: Clin Trial – volume: 46 start-page: 7 year: 2016 end-page: 10 article-title: Discussion on the paper "Real‐time prediction of clinical trial enrollment and event counts: a review", by DF Heitjan, Z Ge, and GS Ying publication-title: Contemp Clin Trials – volume: 32 start-page: 755 issue: 5 year: 2011 end-page: 759 article-title: A hybrid approach to predicting events in clinical trials with time‐to‐event outcomes publication-title: Contemp Clin Trials – volume: 50 start-page: 61 issue: 1 year: 1994 end-page: 76 article-title: Hazard rate estimation under random censoring with varying kernels and bandwidths publication-title: Biometrics – volume: 40 start-page: 3684 issue: 19‐20 year: 2011 end-page: 3699 article-title: Statistical modeling of clinical trials (recruitment and randomization) publication-title: Commun Stat Theory Methods – volume: 16 start-page: 343 issue: 3 year: 2006 end-page: 356 article-title: Predicting event times in clinical trials when treatment arm is masked publication-title: J Biopharm Stat – volume: 26 start-page: 4958 issue: 27 year: 2007 end-page: 4975 article-title: Modelling, prediction and adaptive adjustment of recruitment in multicentre trials publication-title: Stat Med – volume: 54 start-page: 735 issue: 6 year: 2012 end-page: 749 article-title: Joint monitoring and prediction of accrual and event times in clinical trials publication-title: Biometr J – volume: 20 start-page: 2055 issue: 14 year: 2001 end-page: 2063 article-title: Predicting analysis times in randomized clinical trials publication-title: Stat Med – start-page: 361 year: 2020 end-page: 408 – volume: 45 start-page: 26 year: 2015 article-title: Real‐time prediction of clinical trial enrollment and event counts: a review publication-title: Contemp Clin Trials – ident: e_1_2_8_4_1 doi: 10.1002/sim.2956 – ident: e_1_2_8_19_1 doi: 10.1002/sim.1576 – start-page: 361 volume-title: Modern Analytic Techniques for Predictive Modeling of Clinical Trial Operations year: 2020 ident: e_1_2_8_7_1 – ident: e_1_2_8_8_1 doi: 10.1002/sim.8036 – ident: e_1_2_8_2_1 doi: 10.1016/j.cct.2015.07.010 – ident: e_1_2_8_11_1 doi: 10.1177/1740774517750633 – ident: e_1_2_8_14_1 – ident: e_1_2_8_9_1 doi: 10.1002/pst.525 – ident: e_1_2_8_13_1 doi: 10.1080/10543400600609445 – ident: e_1_2_8_20_1 doi: 10.1016/j.cct.2015.11.008 – ident: e_1_2_8_18_1 doi: 10.1191/1740774504cn030oa – ident: e_1_2_8_3_1 doi: 10.1002/sim.843 – ident: e_1_2_8_6_1 doi: 10.1080/03610926.2011.581189 – ident: e_1_2_8_12_1 doi: 10.1002/pst.271 – ident: e_1_2_8_10_1 doi: 10.1016/j.cct.2011.05.013 – ident: e_1_2_8_15_1 doi: 10.1002/bimj.201100180 – ident: e_1_2_8_5_1 doi: 10.1007/978-3-7908-1952-6_1 – ident: e_1_2_8_16_1 doi: 10.2307/2533197 – ident: e_1_2_8_17_1 doi: 10.1007/978-0-387-84858-7 |
SSID | ssj0011527 |
Score | 2.4053319 |
Snippet | In clinical trials, almost all key milestone dates can be defined in terms of time to endpoint maturation (TTEM). The real time monitoring and accurate... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3596 |
SubjectTerms | Bayesian Clinical trials enrollment Poisson process time to event |
Title | Real time monitoring and prediction of time to endpoint maturation in clinical trials |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fsim.9436 https://www.ncbi.nlm.nih.gov/pubmed/35587584 https://www.proquest.com/docview/2690130769 https://www.proquest.com/docview/2667785312 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0277-6715 databaseCode: DR2 dateStart: 19960101 customDbUrl: isFulltext: true eissn: 1097-0258 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0011527 providerName: Wiley-Blackwell |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1LS8QwEIAH8SAL4mN91RcRRE9d2zTptkcRRYX1oC4IHkrSpLDotstu9-KvN9O0FV8gnlra6XMmk2nS-Qbg2FM8VlxEbiQ8z2UpY24URr5LY6ozLwvSlGOi8OAuvB6y2yf-VP9Vibkwlg_RDrhhy6j8NTZwIWdnH9DQ2Wjci1mAtG0_4NUM7X1LjvKbaq04Qxn2fd5wZz161hz4uSf6Fl5-jlar7uZqFZ6bG7V_mbz05qXspW9fGI7_e5I1WKmjUHJuzWYdFnTehaVBPc_ehWU7mkdsklIXOhiTWqTzBgzvzVaCRenJuPIIODRIRK7IZIpnQFWTIrMSZUF0ribFKC_JGCGilSWQUU6anExSFQ6ZbcLw6vLx4tqtqzO4KULmXaaMjiXi3xAmmsWir83nbqaFWadBrJn2Qymk9LkSkYqC1Mj2PS6zvmaRilWwBYt5kesdIMIT2uOailBIpnxfiNj44SALAyaMJYUOnDaaStIaXY4VNF4TC12miXmFCb5CB45ayYnFdfwgs98oO6kb7CyhWJjL-LswNqdod5umhvMnItfFHGWQtmecFnVg2xpJexGk1JtPL-bASaXqX6-ePNwMcLn7V8E96FBMuUAML9-HxXI61wcmECrlYWXy7-bIBMY |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED9BJwES2kbHR8fHjITgKSVxbDcRT2hbVTbKA1CJB6TIiR2pgiYVTV_46_HFSRCwSYinRMnFTnwfPp9zvwM4cBUPFZeBE0jXdVjCmBOIwHNoSHXqpn6ScEwUHl6IwYj9ueE3C3BS58JYfIgm4IaaUdprVHAMSB8_o4bOxpNuyHyxCJ9wew618tdlgx3l1fVacY9S9DxeI8-69Lh-8uVc9MbBfOmvlhNO_wvc1q9q_zO5686LuJs8vkJx_OC3fIXPlSNKTq3krMGCztqwNKy22tuwagN6xOYptWEF3VKL6vwNRpfmKsG69GRSGgWMDhKZKTJ9wBaQ2yRPLUWRE52paT7OCjJBHNFSGMg4I3VaJilrh8zWYdT_ff1z4FQFGpwEceYdpgybY0SAQzzRNJQ9bVa8qZbmnPqhZtoTsYxjjysZqMBPDG3P5XHa0yxQofI3oJXlmd4CIl2pXa6pFDJmyvOkDI0p9lPhM2mESXTgqGZVlFTo5VhE4z6yuMs0MkMY4RB2YL-hnFrEjn_Q7NTcjiqdnUUUa3MZkydC00Rz22gbbqHITOdzpEHAPWO3aAc2rZQ0nSBQvVl9sQ4clrz-b-_R1dkQj9_fS_gDlgfXw_Po_Ozi7zasUMzAQFRevgOt4mGud41fVMR7pfw_ASV-COI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3dS-QwEMAHT0EEOXU9vfUzgnhPXds0ybaPoi5-rYi6IPhQ0iaFxdt2cbsv99ebadqKHwfiU0s7_ZzJdJJ0fgOw7yoeKi4DJ5Cu67CEMScQgefQkOrUTf0k4Zgo3L8WZwN28cAfqr8qMRfG8iGaATdsGaW_xgY-VunhKzR0Mhx1QuaLHzDHhOlcYUB026CjvLpcK05Riq7Ha_CsSw_rI99-ij7El2_D1fJ701uCx_pO7W8mT51pEXeSf-8gjt97lGX4WYWh5MjazQrM6KwF8_1qor0Fi3Y4j9gspRYsYFBqmc6rMLg1WwlWpSej0iXg2CCRmSLjZzwD6prkqZUocqIzNc6HWUFGSBEtTYEMM1InZZKycsjkFwx6p_fHZ05VnsFJkDLvMGWUHCP_DWmiaSi72vR3Uy3NOvVDzbQnYhnHHlcyUIGfGNmuy-O0q1mgQuWvwWyWZ_o3EOlK7XJNpZAxU54nZWgcsZ8Kn0ljSqINf2pNRUnFLscSGn8jS12mkXmFEb7CNuw1kmPL6_hEZqtWdlS12ElEsTKXcXgiNKdodpu2hhMoMtP5FGUQt2e8Fm3DujWS5iKIqTd9L9aGg1LV_716dHfex-XGVwV3Yf7mpBddnV9fbsICxfQLRPLyLZgtnqd62wRFRbxTWv8LC04HkQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Real+time+monitoring+and+prediction+of+time+to+endpoint+maturation+in+clinical+trials&rft.jtitle=Statistics+in+medicine&rft.au=Wang%2C+Li&rft.au=Liu%2C+Yang&rft.au=Chen%2C+Xiaotian&rft.au=Pulkstenis%2C+Erik&rft.date=2022-08-15&rft.issn=0277-6715&rft.eissn=1097-0258&rft.volume=41&rft.issue=18&rft.spage=3596&rft.epage=3611&rft_id=info:doi/10.1002%2Fsim.9436&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_sim_9436 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-6715&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-6715&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-6715&client=summon |